Skip to main content
. 2020 Oct 2;11:580867. doi: 10.3389/fimmu.2020.580867

TABLE 2.

SARS-CoV-2 specific RNA and binding and neutralizing antibodies in plasma from all studied patients.

Antibody reactivity (AU)*
ID RT-PCR IgG* IgA* IgM* Neutralization
S1 – S2 – NP – S S1 – S2 – NP S1 – S2 – NP IC50**
Pat.#1 Positive 4.6 – 4.8 – 6.3 – <12 6.4 – 3.7 – 2 3.4 – 4.5 – 4.3 <60
Pat.#2 Negative 31 – 16 – 34 –>15 40.5 – 21 – 29.5 20 – 7.3 – 17 8100
Controls/16 Male Positive 23.2 – 14 – 20.5 – ND*** 28.6 – 12.8 – 18.2 17.5 – 5.6 – 18.2 850 (range <60–6800)
Controls/12 Female Positive 20.6 – 15.2 – 22 – ND*** 26.3 – 11 – 20.8 16.3 – 4.8 – 16.9 1160 (range <60–10622)

*AU stands for Arbitrary Unit. It has been calculated following the formula: median OD sample x10/cut off value. **IC50 stands for dilution of sera inhibiting 50% of infection. ***ND stands for not determined.